Abstract: A nanocomposite comprising collagen nanoparticles loaded with abscisic acid (ABA). can have an average particle diameter ranging from about 125 nm to about 185 nm. Collagen in the collagen nanoparticles can be derived from a marine source. The nanocomposite can effectively treat and prevent cardiac ischemia.

Abstract: An 9-(2-hydroxypyridin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione compound, its synthesis, and its use as an antimicrobial agent.

Abstract: The disclosure of the present patent application relates generally to the extraction and purification of abscisic acid (ABA) from strawberries and its application in medicine and disease treatment in mammals and specifically humans. The extraction and purification process uses gel column chromatography to provide a highly pure composition of ABA, and the application of such includes treating heart disease.

Abstract: An 5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid compound, its synthesis, and its use as an antimicrobial agent.

Abstract: Synthesis of a compound N-[(1-phenyl-4H-1,2,4-triazol-3-yl)carbamothioyl]benzamide and its use as an insecticidal agent.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(nicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: A compound 3,3?-(hydrazine-1.2-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol), its synthesis, and its use as an insecticidal agent.

Abstract: A combination treatment for antibiotic resistant infections is provided. The combination treatment for antibiotic resistant infections includes zinc oxide nanoparticles loaded with linezolid and ceftriaxone. The combination treatment may be formulated for administration by any desired route, including particularly oral administration or topical administration. The combination treatment may be administered to a subject in need thereof to treat a bacterial infection. The bacterial infection may be caused by any bacterium, including an antibiotic resistant bacterium. The combination treatment may be formulated in a gel for topical administration to improve wound healing and to treat a MRSA infection.

Abstract: A combination treatment for antibiotic resistant infections is provided. The combination treatment for antibiotic resistant infections includes zinc oxide nanoparticles loaded with linezolid and ceftriaxone. The combination treatment may be formulated for administration by any desired route, including particularly oral administration or topical administration. The combination treatment may be administered to a subject in need thereof to treat a bacterial infection. The bacterial infection may be caused by any bacterium, including an antibiotic resistant bacterium. The combination treatment may be formulated in a gel for topical administration to improve wound healing and to treat a MRSA infection.

Abstract: A combination treatment for antibiotic resistant infections is provided. The combination treatment for antibiotic resistant infections includes zinc oxide nanoparticles loaded with linezolid and ceftriaxone. The combination treatment may be formulated for administration by any desired route, including particularly oral administration or topical administration. The combination treatment may be administered to a subject in need thereof to treat a bacterial infection. The bacterial infection may be caused by any bacterium, including an antibiotic resistant bacterium. The combination treatment may be formulated in a gel for topical administration to improve wound healing and to treat a MRSA infection.

Abstract: A combination treatment for antibiotic resistant infections is provided. The combination treatment for antibiotic resistant infections includes zinc oxide nanoparticles loaded with linezolid and ceftriaxone. The combination treatment may be formulated for administration by any desired route, including particularly oral administration or topical administration. The combination treatment may be administered to a subject in need thereof to treat a bacterial infection. The bacterial infection may be caused by any bacterium, including an antibiotic resistant bacterium. The combination treatment may be formulated in a gel for topical administration to improve wound healing and to treat a MRSA infection.

Abstract: A photochromic material can include nanoparticles of lanthanide-activated strontium aluminate (NLSA) embedded into polyethylene terephthalate (PET). The PET may further include electrospun polypropylene nanofibers (PPNF) incorporated therein. In some embodiments, the photochromic material may be transparent. In other embodiments, the photochromic material may be scratch resistant. In some embodiments, the photochromic material may be configured to form concrete. In still other embodiments, the photochromic material may be configured to form windows. The electrospun polypropylene nanofibers may be a roughening agent in the PET. The photochromic material may exhibit a green coloration after exposure to ultraviolet (UV) light. The NLSA may have a diameter of about 80 nm to about 120 nm. The PPNF may have a diameter of about 75 nm to about 180 nm. The photochromic material may be superhydrophobic.

Abstract: Novel organoselenium selective ligands are presented and designed to determine metal ions in a sample. These ligands are used as complexing agents in a dispersive liquid-liquid microextraction procedure of copper and zinc ions. The procedure has a shortened extraction time, minimal organic solvent types, and lower amounts of solvents, as well as easy operation and high enrichment efficiency.

Abstract: Cobalt and copper-doped nickel Cu/Co—Ni-ferrite nanoparticles having a general formula CuxCoxNi(1-x)Fe2O4 can be a catalyst for electrooxidation of methanol in direct methanol fuel cells (DMFC). The catalyst can be an efficient anode for DMFC in alkaline electrolytes. The Cu/Co—Ni-ferrite nanoparticles can have a sponge-like structure with irregular pores. A diameter of the Cu/Co—Ni-ferrite nanoparticles can range from about 8 nm to about 30 nm.

Abstract: Cobalt and copper-doped nickel Cu/Co—Ni-ferrite nanoparticles having a general formula CuxCoxNi(1-x)Fe2O4 can be a catalyst for electrooxidation of methanol in direct methanol fuel cells (DMFC). The catalyst can be an efficient anode for DMFC in alkaline electrolytes. The Cu/Co—Ni-ferrite nanoparticles can have a sponge-like structure with irregular pores. A diameter of the Cu/Co—Ni-ferrite nanoparticles can range from about 8 nm to about 30 nm.

Abstract: A 4-chloro-N?-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: Novel organoselenium selective ligands are presented and designed to determine metal ions in a sample. These ligands are used as complexing agents in a dispersive liquid-liquid microextraction procedure of copper and zinc ions. The procedure has a shortened extraction time, minimal organic solvent types, and lower amounts of solvents, as well as easy operation and high enrichment efficiency.

Abstract: A combination treatment for antibiotic resistant infections is provided. The combination treatment for antibiotic resistant infections includes zinc oxide nanoparticles loaded with linezolid and ceftriaxone. The combination treatment may be formulated for administration by any desired route, including particularly oral administration or topical administration. The combination treatment may be administered to a subject in need thereof to treat a bacterial infection. The bacterial infection may be caused by any bacterium, including an antibiotic resistant bacterium. The combination treatment may be formulated in a gel for topical administration to improve wound healing and to treat a MRSA infection.

Abstract: Methods of making polyvinylidene fluoride nanoparticles fine powder (PVDFNPs) and copper nanoparticles (CUNPs) from spent green coffee grounds extract. Using the formed PVDFNPs and CUNPs to produce copper nanoparticles-polyvinylidene fluoride nanoparticles nanocomposite fine powder (CuNPs@PVDFNPs) for eliminating pathogenic contaminants (i.e., Salmonella enterica, Klebsiella pneumoniae, Bacillus subtilis, Enterococcus faecalis) from an aqueous solution (i.e., wastewater).

Abstract: Lignocellulose based hydrogels (LCHs) derived from date palm (DP) waste that can be used to overcome water treatment challenges, as well as a preparation method and application thereof.